Cancer health disparities in racial/ethnic minorities in the United States

VA Zavala, PM Bracci, JM Carethers… - British journal of …, 2021 - nature.com
There are well-established disparities in cancer incidence and outcomes by race/ethnicity
that result from the interplay between structural, socioeconomic, socio-environmental …

[HTML][HTML] Advances in understanding the role of P-gp in doxorubicin resistance: Molecular pathways, therapeutic strategies, and prospects

S Mirzaei, MH Gholami, F Hashemi, A Zabolian… - Drug Discovery …, 2022 - Elsevier
Abstract P-glycoprotein (P-gp) is a drug efflux transporter that triggers doxorubicin (DOX)
resistance. In this review, we highlight the molecular avenues regulating P-gp, such as Nrf2 …

[HTML][HTML] Management of patients with advanced prostate cancer: report of the advanced prostate cancer consensus conference 2019

S Gillessen, G Attard, TM Beer, H Beltran, A Bjartell… - European urology, 2020 - Elsevier
Background Innovations in treatments, imaging, and molecular characterisation in advanced
prostate cancer have improved outcomes, but there are still many aspects of management …

A whole-genome reference panel of 14,393 individuals for East Asian populations accelerates discovery of rare functional variants

J Choi, S Kim, J Kim, HY Son, SK Yoo, CU Kim… - Science …, 2023 - science.org
Underrepresentation of non-European (EUR) populations hinders growth of global precision
medicine. Resources such as imputation reference panels that match the study population …

Prostate cancer racial disparities: a systematic review by the prostate cancer foundation panel

BA Mahal, T Gerke, S Awasthi, HR Soule… - European urology …, 2022 - Elsevier
Abstract Context Prostate cancer (PCa) is a complex disease that disproportionately impacts
Black men in the USA. The structural factors that drive heterogeneous outcomes for patients …

[HTML][HTML] African-specific molecular taxonomy of prostate cancer

W Jaratlerdsiri, J Jiang, T Gong, SM Patrick, C Willet… - Nature, 2022 - nature.com
Prostate cancer is characterized by considerable geo-ethnic disparity. African ancestry is a
significant risk factor, with mortality rates across sub-Saharan Africa of 2.7-fold higher than …

Cellular and molecular mechanisms underlying prostate cancer development: therapeutic implications

U Testa, G Castelli, E Pelosi - Medicines, 2019 - mdpi.com
Prostate cancer is the most frequent nonskin cancer and second most common cause of
cancer-related deaths in man. Prostate cancer is a clinically heterogeneous disease with …

Tumor sequencing of African ancestry reveals differences in clinically relevant alterations across common cancers

E Jiagge, DX **, JY Newberg, T Perea-Chamblee… - Cancer cell, 2023 - cell.com
Cancer genomes from patients with African (AFR) ancestry have been poorly studied in
clinical research. We leverage two large genomic cohorts to investigate the relationship …

Survival of African-American and Caucasian men after sipuleucel-T immunotherapy: outcomes from the PROCEED registry

O Sartor, AJ Armstrong, C Ahaghotu… - Prostate cancer and …, 2020 - nature.com
Abstract Purpose African Americans experience greater prostate cancer risk and mortality
than do Caucasians. An analysis of pooled phase III data suggested differences in overall …

Integrative comparison of the genomic and transcriptomic landscape between prostate cancer patients of predominantly African or European genetic ancestry

J Yuan, KH Kensler, Z Hu, Y Zhang, T Zhang… - PLoS …, 2020 - journals.plos.org
Men of predominantly African Ancestry (AA) have higher prostate cancer (CaP) incidence
and worse survival than men of predominantly European Ancestry (EA). While …